@xconomy.com 1 year ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com 1 year ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com 1 year ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com 1 year ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans